Icosavax, Inc.

NASDAQ:ICVX

15.31 (USD) • At close February 16, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Revenue 0000000-5.7321.8271.9042.0010000
Cost of Revenue 0.7630.6650.6431.6020.1430000000000
Gross Profit -0.763-0.665-0.643-1.602-0.14300-5.7321.8271.9042.0010000
Gross Profit Ratio 000000011110000
Reseach & Development Expenses 16.66819.82617.35716.19315.48415.8217.91314.06310.8838.2775.5535.3294.7524.6662.92
General & Administrative Expenses 8.6079.1299.1658.9387.6597.3116.3226.21825.3572.2211.0910.8020.7040.5410.612
Selling & Marketing Expenses 000000000000000
SG&A 8.6079.1299.1658.9387.6597.3116.3226.21825.3572.2211.0910.8020.7040.5410.612
Other Expenses 0000.58200-0.582000-0.205-1.616000
Operating Expenses 25.27528.95526.52225.13123.14323.13123.65318.21134.4138.5944.6434.5155.4565.2073.532
Operating Income -25.275-28.955-26.522-25.131-23.143-23.131-23.653-18.211-34.413-8.594-4.643-4.515-5.456-5.207-3.532
Operating Income Ratio 00000003.177-18.836-4.514-2.320000
Total Other Income Expenses Net 3.2342.4581.9611.5181.1670.4950.1232.6140.0270.042-0.959-0.093-0.1210.0090.061
Income Before Tax -22.041-26.497-24.561-23.613-21.976-22.636-23.533-18.182-34.386-8.552-5.851-4.608-5.577-5.198-3.471
Income Before Tax Ratio 00000003.172-18.821-4.492-2.9240000
Income Tax Expense -0.763-0.665-1.961-2.133-1.167-0.495-0.1232.549000.2490000
Net Income -22.041-26.497-22.6-21.48-20.809-22.141-23.413-18.182-34.386-8.552-5.851-4.608-5.577-5.198-3.471
Net Income Ratio 00000003.172-18.821-4.492-2.9240000
EPS -0.44-0.59-0.55-0.54-0.52-0.56-0.59-0.46-1.3-2.86-1.96-1.6-1.87-1.74-0.23
EPS Diluted -0.44-0.59-0.55-0.54-0.52-0.56-0.59-0.46-1.3-2.86-1.96-1.6-1.87-1.74-0.23
EBITDA -25.275-28.955-26.522-25.131-23-23.076-23.61-18.211-34.384-8.578-4.642-4.514-5.456-5.207-3.532
EBITDA Ratio 00000003.177-18.82-4.505-2.320000